This book covers key extents of Pharmaceutical Research. The contributions for one authors contain endometrial cancer, Histopathology, PI3K/AKT/mTOR road, p53 and p16 change, Wnt/β-catenin signaling road, HER2/neu change, Liquid chromatography–mass spectrometry, tucatinib, degradation pathways, supersaturable SNEDDS, drizzle inhibitors, solubility, cancer, nanodrugs, nanotechnology, beginning pelvic tilt, reduced back pain, therapeutic plants, phytomedicine, antimicrobial opposition, bacterial contaminations, bioenhancers, CYP enzyme inhibitors, hindrance of P-gp outflow transporter, piperine, naringin, hoof reflexology, hemodialysis, anxiety, hemodialysis subjects, fruit seed extracts, completely clean endeavor, antifungal, inflammatory bowel ailment, chemically inferred colitis, dextran sulfate sodium, trinitro benzene sulfonic acid, acetic acid-persuaded colitis, oxazolone-induced colitis, indomethacin-inferred colitis, and carrageenan-inferred colitis. This book contains differing matters suitable for graduates, analysts and academicians in the field of Pharmaceutical Research.
Dr. Takashi Ikeno,
National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Please see the link here: https://stm.bookpi.org/CAPR-V10/article/view/8805
Keywords: Potential genotoxic impurities, dasatinib drug, ultra-fast LC, validation